Cited by 104Coenzyme Q10 studies and effectsNitric Oxide and Endothelin EffectsMitochondrial Function and Pathology

Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: A randomized controlled trial

Dai, Yuk-Ling, Luk, Ting-Hin, Yiu, Kai-Hang, Wang, Mei, Yip, Pandora M.C., Lee, Stephen W.L., Li, Sheung-Wai, Tam, Sidney +4 more·2011·Atherosclerosis

Abstract

Aims Coronary artery disease (CAD) is associated with endothelial dysfunction and mitochondrial dysfunction (MD). The aim of this study was to investigate whether co-enzyme Q10 (CoQ) supplementation, which is an obligatory coenzyme in the mitochondrial respiratory transport chain, can reverse MD and improve endothelial function in patients with ischaemic left ventricular systolic dysfunction (LVSD).Methods and results We performed a randomized, double-blind, placebo-controlled trial to determine the effects of CoQ supplement (300 mg/day, n=28) vs. placebo (controls, n=28) for 8 weeks on brachial flow-mediated dilation (FMD) in patients with ischaemic LVSD(left ventricular ejection fraction <45%). Mitochondrial function was determined by plasma lactate/pyruvate ratio (LP ratio). After 8 weeks, CoQ-treated patients had significant increases in plasma CoQ concentration (treatment effect 2.20 μg/mL, P<0.001) and FMD (treatment effect 1.51%, P=0.03); and decrease in LP ratio (treatment effect -2.46, P=0.03) compared with controls. However, CoQ treatment did not alter nitroglycerin-mediated dilation, blood pressure, blood levels of fasting glucose, haemoglobin A1c, lipid profile, high-sensitivity C-reactive protein and oxidative stress as determined by serum superoxide dismutase and 8-isoprostane (all P>0.05). Furthermore, the reduction in LP ratio significantly correlated with improvement in FMD (r=-0.29, P=0.047).Conclusion In patients with ischaemic LVSD, 8 weeks supplement of CoQ improved mitochondrial function and FMD; and the improvement of FMD correlated with the change in mitochondrial function, suggesting that CoQ improved endothelial function via reversal of mitochondrial dysfunction in patients with ischaemic LVSD.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2011.02.013

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dai, Y.-L., Luk, T.-H., Yiu, K.-H., Wang, M., Yip, P. M. C., Lee, S. W. L., Li, S.-W., Tam, S., Fong, B., Lau, C.-P., Siu, C.-W., & Tse, H.-F.
Affiliations
  • University of Hong Kong (HK)
  • Tung Wah Hospital (CN)
  • Queen Mary Hospital (CN)
Corresponding author
Tse, Hung-Fat
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2011-06
Volume
216
Issue
2
Pages
395-401
ISSN
0021-9150 (ISSN-L)
OpenAlex
W2042702713
Cited by
104
References
31
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 9 · 2012: 6
FWCI
3.11
Type
journal article
Language
en
Open access
closed
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
Funders
  • CRCG Small Project Funding of University of Hong Kong (200907176063)
  • Sun Chieh Yeh Heart Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
coenzyme Q10 supplementation, mitochondrial dysfunction, endothelial dysfunction, coronary artery disease, flow-mediated dilation, lactate/pyruvate ratio, mitochondrial function, nitric oxide bioavailability
MeSH terms
Aged, Blood Pressure, Brachial Artery, Cross-Sectional Studies, Double-Blind Method, Endothelium, Vascular, Female, Nitroglycerin, Humans, Male, Middle Aged, Placebos, Risk Factors, Superoxide Dismutase, Ubiquinone, Dinoprost, Ventricular Dysfunction, Left, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review